Jeffrey N. Agar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeffrey N. Agar has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
- Nathalie Y. R. Agar
Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
8 shared publications Amin Hossain
Department of Chemistry and Chemical Biology, Northeastern University;Boston, Massachusetts, USA
6 shared publicationsElizabeth C. Randall
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
6 shared publications- Jared R. Auclair
Department of Chemistry and Chemical Biology, Northeastern University, Boston, USA
6 shared publications - Joseph A. Loo
University of California-Los Angeles
6 shared publications - Neil L. Kelleher
Northwestern University
6 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Springer Nature in Communications Chemistry
Intact protein mass spectrometry imaging at isotopic resolution enables assessment of covalent drug candidates
- 8 September 2026
- Published by Springer Nature in Communications Chemistry
Open AccessIntact protein mass spectrometry imaging at isotopic resolution enables assessment of covalent drug candidates
- Open Access
- 26 August 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (35) , 25899-25908
Disambiguation of Product Ion Assignments, Including Internal Fragment Ions from Top-Down Mass Spectrometry, Using Ion Mobility-Aligned Fragmentation (MAF)
Advances in mass spectrometry instrumentation resulted in richer MSn spectra and additional ambiguity in peak assignments. Internal fragment ions (IFs) are often prevalent during top-down mass spectrometry (TDMS) and are particularly difficult to assign─to the extent many practitioners currently forgo their assignment. Accounting for IFs during high-yield dissociation can increase the depth of sequence coverage by an order of magnitude but also results in a geometric increase in the size of the database and ambiguous peak assignments. The ambiguity in TDMS fragment ion assignments comes from the potential for one experimental peak to be assigned to two or more theoretical molecules─most often in the form of isomeric internal fragment ions from distinct sequence regions. The disambiguation of such peaks remains a major challenge in TDMS and is the focus of this work. Ion mobility (IM) mass spectrometry can often separate isomers, including peptides. Starting from a TDMS spectrum containing both unambiguously and ambiguously assigned peaks, we address the hypothesis that ion mobility, or ion mobility followed by fragmentation, can help disambiguate fragment ion assignments by resolving isomeric ambiguity in the mobility domain. We demonstrate that mobility-aligned fragmentation (MAF) can disambiguate TDMS and peptide MS/MS peak assignments of isomeric terminal and internal ions. Consistent with previous studies, we also demonstrate that a single isomeric species (e.g., an individual b-, a-, or internal ion) can be comprised of multiple conformational isomers with different collisional cross-section (CCS) values.
- 26 August 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (35) , 25899-25908
Open AccessDisambiguation of Product Ion Assignments, Including Internal Fragment Ions from Top-Down Mass Spectrometry, Using Ion Mobility-Aligned Fragmentation (MAF)
Advances in mass spectrometry instrumentation resulted in richer MSn spectra and additional ambiguity in peak assignments. Internal fragment ions (IFs) are often prevalent during top-down mass spectrometry (TDMS) and are particularly difficult to assign─to the extent many practitioners currently forgo their assignment. Accounting for IFs during high-yield dissociation can increase the depth of sequence coverage by an order of magnitude but also results in a geometric increase in the size of the database and ambiguous peak assignments. The ambiguity in TDMS fragment ion assignments comes from the potential for one experimental peak to be assigned to two or more theoretical molecules─most often in the form of isomeric internal fragment ions from distinct sequence regions. The disambiguation of such peaks remains a major challenge in TDMS and is the focus of this work. Ion mobility (IM) mass spectrometry can often separate isomers, including peptides. Starting from a TDMS spectrum containing both unambiguously and ambiguously assigned peaks, we address the hypothesis that ion mobility, or ion mobility followed by fragmentation, can help disambiguate fragment ion assignments by resolving isomeric ambiguity in the mobility domain. We demonstrate that mobility-aligned fragmentation (MAF) can disambiguate TDMS and peptide MS/MS peak assignments of isomeric terminal and internal ions. Consistent with previous studies, we also demonstrate that a single isomeric species (e.g., an individual b-, a-, or internal ion) can be comprised of multiple conformational isomers with different collisional cross-section (CCS) values.
- Open Access
- 21 August 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (16)
Cyclic Thiosulfinates: Synthesis and Applications in Chemical Biology and Materials Science
Cyclic thiosulfinates (CTs) constitute a distinct class of organosulfur compounds characterized by a polarized ─S(═O)─S─ motif and inherent ring strain, which together dictate their unique reactivity toward thiols. Recent advances in synthetic methodologies, particularly the controlled oxidation of cyclic disulfides, have enabled access to stable CTs with tunable ring sizes and substitution patterns. Mechanistic studies reveal that ring‐induced hyperconjugation and conformational constraints enhance nucleophilic substitution, allowing for selective cross‐linking of proximal thiols while minimizing the modification of isolated thiols. These properties have positioned CTs as valuable tools in chemical biology for selective thiol targeting and protein cross‐linking in complex biological environments. Concurrently, CTs are gaining prominence as dynamic covalent cross‐linkers in materials science. This review highlights recent progress in the synthesis, reactivity, and applications of CTs across chemical biology and materials science.
- 21 August 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (16)
Open AccessCyclic Thiosulfinates: Synthesis and Applications in Chemical Biology and Materials Science
Cyclic thiosulfinates (CTs) constitute a distinct class of organosulfur compounds characterized by a polarized ─S(═O)─S─ motif and inherent ring strain, which together dictate their unique reactivity toward thiols. Recent advances in synthetic methodologies, particularly the controlled oxidation of cyclic disulfides, have enabled access to stable CTs with tunable ring sizes and substitution patterns. Mechanistic studies reveal that ring‐induced hyperconjugation and conformational constraints enhance nucleophilic substitution, allowing for selective cross‐linking of proximal thiols while minimizing the modification of isolated thiols. These properties have positioned CTs as valuable tools in chemical biology for selective thiol targeting and protein cross‐linking in complex biological environments. Concurrently, CTs are gaining prominence as dynamic covalent cross‐linkers in materials science. This review highlights recent progress in the synthesis, reactivity, and applications of CTs across chemical biology and materials science.
- Open Access
- 13 May 2026
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 40 (16) , e70104
Combinatorial Probabilities of Multiple Fragmentation Events Explain Polypeptide MS/MS Intensity Distribution, Overrepresentation of Smaller Fragments, and Missing Middle of Top‐Down MS
Rationale: Lyon and coworkers demonstrated that multiple random fragmentation events can bias intensity distributions toward smaller terminal fragment ions. With any high‐yield method of dissociation, such as high‐energy collisional activation, this phenomenon can greatly influence the intensity distribution of product ions in MS/MS spectra. Previously, multiple fragmentation events were simulated with computationally intensive stochastic studies. The goal of this work is to provide a mathematical model that explains the results obtained from computational stochastic studies. Methods: We present a probabilistic model that predicts terminal and internal product ion intensities based on polypeptide size and the number of fragmentation events. This model is validated by demonstrating convergence with the previous stochastic model and described that the intensity trend from smaller fragments to larger fragments follows the probability of multiple fragmentation events on peptide backbone. Results: Under the stated assumptions, the analytical expressions formally demonstrate that the “missing middle” is a necessary mathematical consequence of multiple fragmentation events, and they reproduce the stochastic simulation results with exact agreement while reducing computation time from hours to less than 1 s. Our method consistently offers greater accuracy and mathematically proves the mechanistic necessity of “missing middle” phenomenon in top‐down MS. The abundances of fragments from stochastic simulation distribute around the average value calculated by the probability formula within twofold coefficient variance (%CV). Conclusion: The closed‐form probability expressions accurately describe the combinatorial consequences of multiple fragmentation events under the stated assumptions. Because they are computationally inexpensive and differentiable, these expressions could be integrated with sequence‐dependent fragmentation propensities in future machine learning models for MS/MS spectral prediction.
- 13 May 2026
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 40 (16) , e70104
Open AccessCombinatorial Probabilities of Multiple Fragmentation Events Explain Polypeptide MS/MS Intensity Distribution, Overrepresentation of Smaller Fragments, and Missing Middle of Top‐Down MS
Rationale: Lyon and coworkers demonstrated that multiple random fragmentation events can bias intensity distributions toward smaller terminal fragment ions. With any high‐yield method of dissociation, such as high‐energy collisional activation, this phenomenon can greatly influence the intensity distribution of product ions in MS/MS spectra. Previously, multiple fragmentation events were simulated with computationally intensive stochastic studies. The goal of this work is to provide a mathematical model that explains the results obtained from computational stochastic studies. Methods: We present a probabilistic model that predicts terminal and internal product ion intensities based on polypeptide size and the number of fragmentation events. This model is validated by demonstrating convergence with the previous stochastic model and described that the intensity trend from smaller fragments to larger fragments follows the probability of multiple fragmentation events on peptide backbone. Results: Under the stated assumptions, the analytical expressions formally demonstrate that the “missing middle” is a necessary mathematical consequence of multiple fragmentation events, and they reproduce the stochastic simulation results with exact agreement while reducing computation time from hours to less than 1 s. Our method consistently offers greater accuracy and mathematically proves the mechanistic necessity of “missing middle” phenomenon in top‐down MS. The abundances of fragments from stochastic simulation distribute around the average value calculated by the probability formula within twofold coefficient variance (%CV). Conclusion: The closed‐form probability expressions accurately describe the combinatorial consequences of multiple fragmentation events under the stated assumptions. Because they are computationally inexpensive and differentiable, these expressions could be integrated with sequence‐dependent fragmentation propensities in future machine learning models for MS/MS spectral prediction.
- Open Access
- 19 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug development
Covalent drug discovery efforts are growing rapidly but have major unaddressed limitations. These include high false positive rates during hit-to-lead identification; the inherent uncoupling of covalent drug concentration and effect [i.e., uncoupling of pharmacokinetics (PK) and pharmacodynamics (PD)]; and a lack of bioanalytical and modeling methods for determining PK and PD parameters. We present a covalent drug discovery workflow that addresses these limitations. Our bioanalytical methods are based upon a mass spectrometry (MS) assay that can measure the percentage of drug-target protein conjugation (% target engagement) in biological matrices. Further we develop an intact protein PK/PD model (iPK/PD) that outputs PK parameters (absorption and distribution) as well as PD parameters (mechanism of action, protein metabolic half-lives, dose, regimen, effect) based on time-dependent target engagement data. Notably, the iPK/PD model is applicable to any measurement (e.g., bottom-up MS and other drug binding studies) that yields % of target engaged. A Decision Tree is presented to guide researchers through the covalent drug development process. Our bioanalytical methods and the Decision Tree are applied to two approved drugs (ibrutinib and sotorasib); the most common plasma off-target, human serum albumin; three protein targets (KRAS, BTK, SOD1), and to a promising SOD1-targeting ALS drug candidates.
- 19 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessMass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug development
Covalent drug discovery efforts are growing rapidly but have major unaddressed limitations. These include high false positive rates during hit-to-lead identification; the inherent uncoupling of covalent drug concentration and effect [i.e., uncoupling of pharmacokinetics (PK) and pharmacodynamics (PD)]; and a lack of bioanalytical and modeling methods for determining PK and PD parameters. We present a covalent drug discovery workflow that addresses these limitations. Our bioanalytical methods are based upon a mass spectrometry (MS) assay that can measure the percentage of drug-target protein conjugation (% target engagement) in biological matrices. Further we develop an intact protein PK/PD model (iPK/PD) that outputs PK parameters (absorption and distribution) as well as PD parameters (mechanism of action, protein metabolic half-lives, dose, regimen, effect) based on time-dependent target engagement data. Notably, the iPK/PD model is applicable to any measurement (e.g., bottom-up MS and other drug binding studies) that yields % of target engaged. A Decision Tree is presented to guide researchers through the covalent drug development process. Our bioanalytical methods and the Decision Tree are applied to two approved drugs (ibrutinib and sotorasib); the most common plasma off-target, human serum albumin; three protein targets (KRAS, BTK, SOD1), and to a promising SOD1-targeting ALS drug candidates.
- 14 May 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (12) , 2388-2396
Top-down mass spectrometry of native proteoforms and their complexes: a community study
The combination of native electrospray ionization with top-down fragmentation in mass spectrometry (MS) allows simultaneous determination of the stoichiometry of noncovalent complexes and identification of their component proteoforms and cofactors. Although this approach is powerful, both native MS and top-down MS are not yet well standardized, and only a limited number of laboratories regularly carry out this type of research. To address this challenge, the Consortium for Top-Down Proteomics initiated a study to develop and test protocols for native MS combined with top-down fragmentation of proteins and protein complexes across 11 instruments in nine laboratories. Here we report the summary of the outcomes to provide robust benchmarks and a valuable entry point for the scientific community.
- 14 May 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (12) , 2388-2396
Top-down mass spectrometry of native proteoforms and their complexes: a community study
The combination of native electrospray ionization with top-down fragmentation in mass spectrometry (MS) allows simultaneous determination of the stoichiometry of noncovalent complexes and identification of their component proteoforms and cofactors. Although this approach is powerful, both native MS and top-down MS are not yet well standardized, and only a limited number of laboratories regularly carry out this type of research. To address this challenge, the Consortium for Top-Down Proteomics initiated a study to develop and test protocols for native MS combined with top-down fragmentation of proteins and protein complexes across 11 instruments in nine laboratories. Here we report the summary of the outcomes to provide robust benchmarks and a valuable entry point for the scientific community.
- Open Access
- 23 August 2023
- Published by Springer Nature in Research Square
Top-down mass spectrometry of native proteoforms and their complexes: A community study
The combination of native electrospray ionisation with top-down fragmentation in mass spectrometry allows simultaneous determination of the stoichiometry of noncovalent complexes and identification of their component proteoforms and co-factors. While this approach is powerful, both native mass spectrometry and top-down mass spectrometry are not yet well standardised, and only a limited number of laboratories regularly carry out this type of research. To address this challenge, the Consortium for Top-Down Proteomics (CTDP) initiated a study to develop and test protocols for native mass spectrometry combined with top-down fragmentation of proteins and protein complexes across eleven instruments in nine laboratories. The outcomes are summarised in this report to provide robust benchmarks and a valuable entry point for the scientific community.
- 23 August 2023
- Published by Springer Nature in Research Square
Open AccessTop-down mass spectrometry of native proteoforms and their complexes: A community study
The combination of native electrospray ionisation with top-down fragmentation in mass spectrometry allows simultaneous determination of the stoichiometry of noncovalent complexes and identification of their component proteoforms and co-factors. While this approach is powerful, both native mass spectrometry and top-down mass spectrometry are not yet well standardised, and only a limited number of laboratories regularly carry out this type of research. To address this challenge, the Consortium for Top-Down Proteomics (CTDP) initiated a study to develop and test protocols for native mass spectrometry combined with top-down fragmentation of proteins and protein complexes across eleven instruments in nine laboratories. The outcomes are summarised in this report to provide robust benchmarks and a valuable entry point for the scientific community.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1-S4, Table S1 from Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging
S1. Segmentation map of a subset of lower Gleason tissue specimens, demonstrates regional differences between tumor and normal tissue, and between the two different Gleason grades S2. Example MALDI ion images of 2 long chain acylcarnitine species S3. Annotated H&E and serial frozen sections of human prostate tissue S4. Scores plot from PLSDA multivariate analysis of LESA MS data from tumor and normal prostate tissue Table 1. Pathological description of specimens used for MALDI MSI, cases were staged according to AJCC TNM 8th edition
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1-S4, Table S1 from Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging
S1. Segmentation map of a subset of lower Gleason tissue specimens, demonstrates regional differences between tumor and normal tissue, and between the two different Gleason grades S2. Example MALDI ion images of 2 long chain acylcarnitine species S3. Annotated H&E and serial frozen sections of human prostate tissue S4. Scores plot from PLSDA multivariate analysis of LESA MS data from tumor and normal prostate tissue Table 1. Pathological description of specimens used for MALDI MSI, cases were staged according to AJCC TNM 8th edition
- Top Cited PapersOpen Access
- 12 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (46)
The Human Proteoform Project: Defining the human proteome
An ambitious initiative is proposed to generate a definitive reference set of human proteoforms.
- 12 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (46)
Top Cited PapersOpen AccessThe Human Proteoform Project: Defining the human proteome
An ambitious initiative is proposed to generate a definitive reference set of human proteoforms.